LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis
- Texas A&M Health Science Center, United States
- Texas A&M University College of Veterinary Medicine and Biomedical Sciences, United States
Abstract
The Parkinson's Disease (PD)-associated gene leucine-rich repeat kinase (LRRK2) has been studied extensively in the brain. However, several studies have established that mutations in LRRK2 confer susceptibility to mycobacterial infection, suggesting LRRK2 also controls immunity. We demonstrate that loss of LRRK2 in macrophages induces elevated basal levels of type I interferons (IFN) and interferon stimulated genes (ISGs) and causes blunted interferon responses to mycobacterial pathogens and cytosolic nucleic acid agonists. Altered innate immune gene expression in Lrrk2 knockout (KO) macrophages is driven by a combination of mitochondrial stresses, including oxidative stress from low levels of purine metabolites and DRP1-dependent mitochondrial fragmentation. Together, these defects promote mtDNA leakage into the cytosol and chronic cGAS engagement. While Lrrk2 KO mice can control Mycobacterium tuberculosis (Mtb) replication, they have exacerbated inflammation and lower ISG expression in the lungs. These results demonstrate previously unappreciated consequences of LRRK2-dependent mitochondrial defects in controlling innate immune outcomes.
Data availability
All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 and 5.
Article and author information
Author details
Funding
Michael J. Fox Foundation for Parkinson's Research (M1801235)
- Robert O Watson
National Institute of Allergy and Infectious Diseases (R21AI40004)
- Robert O Watson
National Institute of General Medical Sciences (R35GM133720)
- Kristin L Patrick
Parkinson's Disease Foundation
- Chi G Weindel
National Institutes of Health (5T32OD011083-10)
- Krystal J Vail
Michael J. Fox Foundation for Parkinson's Research (12185)
- Robert O Watson
National Institute of Allergy and Infectious Diseases (1R01AI12551)
- Robert O Watson
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Russell E Vance, University of California, Berkeley, United States
Ethics
Animal experimentation: This study followed the recommendations in the Guide for the Care and Use of Laboratory Animals by the National Research Council. All animals were housed, bred, and studied at Texas A&M Health Science Center using protocols reviewed and approved by the institutional animal care and use committee (IACUC) of Texas A&M University (protocol #2018-0125).
Version history
- Received: August 14, 2019
- Accepted: February 14, 2020
- Accepted Manuscript published: February 14, 2020 (version 1)
- Version of Record published: April 15, 2020 (version 2)
Copyright
© 2020, Weindel et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 6,188
- views
-
- 1,071
- downloads
-
- 67
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis
eLife 9:e51071.
https://doi.org/10.7554/eLife.51071
